Event JSON
{
"id": "221d73c15664126ce7fd1f11ba16b6b2c6074d40a337acff124694ad22e7c691",
"pubkey": "4072912b37efcb655f9d23ec0eb8dd091cece50c11747b97f1893a4ab842b0f1",
"created_at": 1711485060,
"kind": 1,
"tags": [
[
"t",
"health"
],
[
"proxy",
"https://newsie.social/users/TheConversationUS/statuses/112163884918601031",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://newsie.social/users/TheConversationUS/statuses/112163884918601031",
"pink.momostr"
]
],
"content": "The price of asthma medication has soared in the U.S. over the past decade and a half. \n\nThe pharmaceutical company Teva sells QVAR RediHaler, a corticosteroid inhaler, for $286 in the U.S.\n\nIn Germany, Teva sells that same inhaler for $9.\n\nhttps://theconversation.com/asthma-meds-have-become-shockingly-unaffordable-but-relief-may-be-on-the-way-222858 \n#health",
"sig": "6bdffc4aa2ab07ca21c6e22a5c5c3c2dda03b0c452fa8a943b2bd15a9d068218a787ee0c0d3f6122773dbbdcc421e90ad3fe97dd35f8e98a8fdf2b4c993e36d9"
}